company tower banner
Solabia Group Company Logo
REDYLESS® is based on an unprecedented molecule, piperonyl glucose, obtained by transferring glucose from sucrose onto piperonyl alcohol with a specific enzyme called glucosyl-transferase. It visibly reduces both transient and established redness, as well as inhibits the activity of receptors that can cause sensitivity to various stress factors, thus preventing flushing.

INCI Name: Piperonyl Acetone

Functions: Anti-Inflammatory

Labeling Claims: Preservative-free

Benefit Claims: Redness Reduction

Certifications & Compliance: ISO 16128

Knowde Enhanced TDS

Identification & Functionality

Cosmetic Ingredients Functions

Features & Benefits

Benefit Claims
Labeling Claims

Applications & Uses

Application Format
Skin Care Applications
Treatment Product Applications
Use Level
2%
Applications
  • Anti-redness day/night care
  • Specific rosacea/erythrosis care
  • Seasonal care (summer/winter)
  • Extreme condition care
  • Sensitive/reactive skin care
  • Care for menopausal women

Properties

Physical Form
Preservatives

None

Regulatory & Compliance

Certifications & Compliance
Regulatory Status

Authorized in EU, USA, Japan, authorized under conditions in Australia and Canada.

Technical Details & Test Data

Mechanism of Action
  • Redyless® offers a unique mode of action allowing daily control of redness, whether transient or established, to restore well-being and comfort to individuals who are subject to it (patent pending).
  • Redyless®  inhibits the activity of heat and food stress sensitivity receptors : TRPA1 and TRPV1, toprevent the appearance of flushes .
  • Redyless®  reorganizes the structure of the vascular network by controlling angiogenesis, stimulating the resistance of vessels to deformation (PECAM-1 marker) and reducing their diameter, to visibly reduce (in intensity and area) redness erythrosis/rosacea type.

Packaging & Availability

Country Availability
Regional Availability
  • Australia
  • Canada
  • Europe
  • Japan
  • USA